Zegeye Regassa

Zegeye Regassa

Auto-generated profile, based on publicly available information

Zegeye Regassa

Nursing Department, Madda Walabu University, Goba Referral Hospital, Bale Goba, Ethiopia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2022 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
Biniyam SahiledengleBiniyam Sahiledengle
Biniyam Sahiledengle
TTTesfaye Assefa Tadesse
Tesfaye Assefa Tadesse
WNWogene Negash
Wogene Negash
ATAnwar Tahir
Anwar Tahir
TRTadele Regasa
Tadele Regasa
DADaniel Atlaw
Daniel Atlaw
Background: Diabetic retinopathy (DR) is the most prevalent microvascular consequence of diabetes mellitus, and it can result in blindness that is irreversible. Due to delayed diagnosis and limited access to diabetic care, the situation is even worse in developing countries. Scientific evidence on the prevalence of DR and its associated factors among diabetes patients in low-income countries, such as Ethiopia, is limited. This study aimed to determine the prevalence of DR and associated factors among adult diabetes patients in southeast Ethiopia. Methods: A hospital-based cross-sectional study was conducted among diabetes patients who visited Madda Walabu University Goba Referral Hospital. Fundus and slit-lamp examination were performed for screening of DR. Multivariate binary logistic regression was computed to identify factors associated with DR. Results: A total of 256 patients (144 men, 56.2%) aged 50.15± 15.71 years were included in the study. The prevalence of any DR was 19.9% (95% CI 15.4%– 25.3%), mild nonproliferative diabetic retinopathy (NPDR) 10.9% (95% CI 7.6%– 15.4%), moderate NPDR 5.9% (95% CI 3.5%– 9.5%), severe NPDR 0.9% (95% CI 0.2%– 3.9%), and proliferative DR 2.3% (95% CI 1.0%– 5.1%). Duration of diabetes ≥ 10 years (AOR 10.22, 95% CI 1.70– 61.44), central obesity (AOR 5.42, 95% CI 1.38– 21.19), overweight/obese (AOR 2.65, 95% CI 1.02– 6.92), lower high-density lipoprotein (HDL) cholesterol (AOR 5.82, 95% CI 1.86– 18.24), moderate triglyceride:HDL cholesterol ratio (AOR 4.13, 95% CI 1.13– 15.15), and urban dwelling (AOR 2.84, 95% CI 1.04– 7.78) were significantly associated with DR. Conclusion: One in every five DM patients had DR. Sociodemographic, anthropometric, and blood lipids were independently associated with DR. To reduce the burden of diabetes, strategies that focus on lifestyle modifications targeted at identified modifiable risk factors are essential.

1 February 2022 in HIV/AIDS - Research and Palliative Care
Verified
Journal Article
Open access
PDF file
AMAyele Mamo
Ayele Mamo
TTTesfaye Assefa Tadesse
Tesfaye Assefa Tadesse
WNWogene Negash
Wogene Negash
YTYOHANNES TEKALEGN
YOHANNES TEKALEGN
Biniyam SahiledengleBiniyam Sahiledengle
Biniyam Sahiledengle
DADaniel Atlaw
Daniel Atlaw
Background: Antiretroviral therapy (ART) regimen failure is linked to an increased risk of disease progression and death, while early detection of ART failure can help to prevent the development of resistance. This study aimed to evaluate virological and immunological ART failure and predictors among HIV-positive adult and adolescent clients in southeast Ethiopia. Methods: A retrospective cohort study was implemented from January 2016 to November 30, 2020; all HIV-positive nave patients on follow-up during the study period from four hospitals were included. Virological and immunological treatment failure was the primary outcome of the study. Cox proportional hazards regression models were employed for analysis. Hazard ratios with 95% confidence intervals were reported and variables with p-values < 0.05 were considered statistically significant predictors of treatment failure. Results: A total of 641 HIV patients’ charts were reviewed, 62.6% of the study participants were females. Of the total study participants, 18.4% and 15% developed virological and immunological ART regimen treatment failure respectively. The median time to virological failure was 40 months. WHO stage IV [AHR = 4.616; 95% CI: (2.136– 9.974)], WHO stage III [AHR = 2.323; 95% CI: (1.317– 4.098)], poor adherence to HAART regimen [AHR = 3.097; 95% CI: (1.349– 7.108)], and fair adherence [AHR = 2.058; 95% CI: (1.234– 3.432)] were significantly associated with virological treatment failure among adolescent and adult study participants in southeast Ethiopia. Conclusion: The prevalence of virological treatment failure was 18.4% (95% CI: 15.4 − 21.4) and the prevalence of immunological treatment failure was 15% (95% CI: 11.8– 18.4). WHO clinical stage III/IV and non-adherence were independent predictors of virological ART treatment failure. Early management of clinical WHO stages and improving patients’ ART regimen adherence are important to decrease the prevalence of ART regimen treatment failure.

1 July 2022 in Diabetes, Metabolic Syndrome and Obesity
Verified
Journal Article
Open access
PDF file
TRTadele Regasa
Tadele Regasa
YDYohannes Dinku
Yohannes Dinku
BGBereket Gezahegn
Bereket Gezahegn
ZFZegeye Feleke
Zegeye Feleke
ZRZegeye Regassa
Zegeye Regassa
MDMengistu Dessie
Mengistu Dessie
Introduction: Acute pancreatitis is auto-cell destruction that is manifested by increased leakage of amylase and lipase into circulation. During pancreatitis, the activity of serum amylase and lipase is elevated three times above the upper limit of the normal range. This elevation was observed in both prediabetic and diabetic patients. Severe acute pancreatitis can result in acute kidney injury and other multi-organ dysfunction, which is one of the reasons for death. Objective: This study aimed to evaluate the elevation of serum amylase and lipase and their distribution at different stages of renal insufficiency among diabetic patients. Methods: This study included 286 diabetic patients (36 type 1 and 250 type 2), and data were collected from May 1 to June 30, 2019. The study design used was an institution-based cross-sectional study. A face-to-face interview was used to collect data, and serum creatinine, amylase, and lipase levels were measured using a chemistry analyzer. For data entry and statistical analysis, respectively, Epidata software version 3.02 and SPSS version 21 were used. Results: The mean serum amylase among diabetic patients suffering from G3b and G4 was 106.79 IU/L ± 118.18 IU/L and 104.85 ± 90.42 IU/L, respectively. Their mean serum lipase activity was 105.07 IU/L ± 127.54 IU/L and 106.98 IU/L ± 88.35 IU/L, respectively. Serum lipase activity was elevated above the normal range and three times above the upper limit of the normal range with a magnitude of 11.2% and 4.2%, respectively. Similarly, 9.1% and 0.7% of diabetic patients had increased serum amylase above the normal range and three-fold above the normal range, respectively. Conclusion: As glomerular filtration decreases, particularly in moderate-to-severe chronic kidney disease, serum amylase and lipase activity rise above the upper limit.

14 March 2022 in HIV/AIDS - Research and Palliative Care
Verified
Journal Article
Open access
AMAyele Mamo
Ayele Mamo
TTTesfaye Assefa Tadesse
Tesfaye Assefa Tadesse
WNWogene Negash
Wogene Negash
YTYOHANNES TEKALEGN
YOHANNES TEKALEGN
Biniyam SahiledengleBiniyam Sahiledengle
Biniyam Sahiledengle
DADaniel Atlaw
Daniel Atlaw
[This corrects the article DOI: 10.2147/HIV.S354716.].